Public Research Snapshot
Soligenix Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates.
SNGX Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway
Soligenix Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z
TickerSNGX
Market Cap12.8M
Cash RunwayRunway 6-12 months
Next Catalystn/a
Pipeline
| Asset | Indication | Modality | Stage | Public Note |
|---|---|---|---|---|
| No public pipeline rows are loaded yet. | ||||
Catalyst Preview
No public catalyst rows matched this view yet.
Cash Runway Preview
Estimated cash runway: Runway 6-12 months.
This is an automated estimate and may differ from company guidance.
Recent SEC Filings
- No public filing rows are loaded yet.
Clinical Trial Activity
| NCT ID | Phase | Status | Enrollment | Primary Completion |
|---|---|---|---|---|
| No public trial rows are loaded yet. | ||||
Scientific Context
- combination_strategy | in combination with vaccines developed previously.” Over 220 Suspected Deaths From Ebola Health officials have been scrambling to contain t
- indication | First Time In A Month
- literature_publication | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor(®) (Mechlorethamine) in the Treatment of CTCL.
- literature_publication | Thermostable bivalent & trivalent filovirus vaccines from insect cells: potency demonstrated after 3 months and 2 years.
- literature_publication | Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection.
Want the full SNGX research brief?
Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.
Get the weekly biotech catalyst watchlistThis page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.